Parkinson's Disease Treatment in China: A Plan Built Around Daily Function

A hand that shakes at rest, increasing difficulty fastening clothes, or feet that hesitate during a turn may bring someone to a neurologist. After diagnosis, the practical questions are often more immediate than the names of treatments: Can I keep working, go out alone, sleep comfortably, or manage meals? Parkinson's care should address those questions. Medicines and rehabilitation are usually the starting point, with adjustments as symptoms, tolerability, and personal priorities change. A visit to China is most useful when it has a defined clinical purpose and a plan for continuing the resulting care at home.

Key takeaways

These excerpts come from the original article. Read the full sections below for context.

Parkinson's disease remains a clinical diagnosis based on history and examination. The clinician looks for bradykinesia, or slowness with characteristic changes in repeated movement, together with rest tremor or rigidity. Other findings can support the diagnosis or raise concern about a different cause. A person can have Parkinson's without prominent shaking, while a person with tremor may have another condition. Drug-induced parkinsonism and other neurological disorders should not automatically receive the same treatment pathway. Movement Disorder Society clinical criteria
Medication can help movement while leaving problems with turning, getting out of bed, crossing a doorway, or managing a second task while walking. Physical therapy assesses gait, balance, strength, and fitness and can select suitable exercises and cueing strategies. Intensity needs to reflect falls, cardiovascular limitations, cognition, and the ability to follow instructions. An online exercise program is not a universal prescription, particularly for someone who freezes, becomes faint on standing, or has recently fallen. American Physical Therapy Association guideline
Possible purposes include confirming the diagnosis, adjusting a complicated medication schedule, assessing troublesome nonmotor symptoms, arranging rehabilitation, or determining whether a procedure is suitable. Send a medication list, previous benefit and side effects, falls history, and original imaging so the hospital can choose the appropriate appointment. A clear clinical diagnosis does not necessarily require every available test. China's 2026 integrated PET/MRI guideline addresses selected questions and diagnostic uncertainty; it should not be turned into a compulsory imaging package for all patients. Chinese integrated PET/MRI guideline

Quick answer

Full guide

Establish which movement disorder is being treated

Parkinson's disease remains a clinical diagnosis based on history and examination. The clinician looks for bradykinesia, or slowness with characteristic changes in repeated movement, together with rest tremor or rigidity. Other findings can support the diagnosis or raise concern about a different cause. A person can have Parkinson's without prominent shaking, while a person with tremor may have another condition. Drug-induced parkinsonism and other neurological disorders should not automatically receive the same treatment pathway. Movement Disorder Society clinical criteria

If the current diagnosis is uncertain, arrange a movement-disorders consultation before committing to a procedure. Bring a history of how symptoms developed, differences between the two sides, falls, swallowing changes, and previous responses to medicine. Short videos may show episodes that do not occur during an appointment, but they supplement rather than replace the examination. Do not deliberately omit medication to create a dramatic recording. New findings during follow-up may appropriately lead the team to revise the diagnosis and the treatment assumptions attached to it.

Turn the treatment goal into something observable

“Feeling better” is difficult to measure. Walking to a nearby shop, dressing before work, turning safely in the bathroom, or finishing a meal without prolonged effort gives the team a clearer objective. Some difficulties may improve with dopaminergic treatment; others need rehabilitation, a swallowing assessment, or management of a nonmotor symptom. It may be sensible to address the problem that most threatens safety or independence first and revisit other priorities at the next appointment.

The fifth edition of the Chinese treatment guideline, published in 2026, emphasizes movement and nonmovement symptoms and continuing multidisciplinary care. This is a useful framework for discussing treatment, rather than interpreting one successful adjustment as a cure. A national care framework does not mean that every hospital offers identical equipment, rehabilitation schedules, or international follow-up. Ask the actual receiving service what it can provide and which parts will require another team. Original Chinese fifth-edition guideline, reproduced with authorship

Start medication according to need, rather than saving it indefinitely

Levodopa is an important treatment for motor symptoms and is generally supplied with a medicine that reduces its breakdown outside the brain. When slowness and stiffness interfere with ordinary life, patients can discuss its use rather than endure disability solely to reserve it for later. The American Academy of Neurology recommends levodopa as the preferential initial dopaminergic treatment for early disease requiring motor treatment, while considering the individual's adverse-effect risks and circumstances. Other drug classes have roles, but they do not make levodopa an automatic last resort. AAN early-treatment guideline

Improved movement after a dose is not evidence that the underlying degenerative process has been reversed. Conversely, incomplete improvement does not by itself prove that the medicine has no value. The LEAP delayed-start trial did not demonstrate a disease-modifying effect of levodopa over its study period. The treatment discussion should therefore focus on useful symptom relief and tolerability, rather than treating either “early treatment uses up the benefit” or “early treatment stops the disease” as an established fact. LEAP randomized study

A usable prescription includes the generic name, formulation, amount per dose, and actual administration times. Immediate-release and longer-release products are not automatically interchangeable tablet for tablet. Report nausea, standing-related dizziness, sleepiness, or changes in perception and behavior so the clinician can judge whether adjustment is needed. If relatives prepare medicines, they should understand that taking the prescribed total number of tablets at convenient times may not reproduce the intended schedule.

Understand the pattern when benefit begins to fluctuate

Some people become slower or stiffer before the next dose is due; these periods may represent wearing off. At other times they develop involuntary movements, or dyskinesia. Both can be described at home as “getting worse,” although the treatment response may differ. A diary linking doses and meals with comfortable movement, difficulty, and involuntary movement can make the consultation much more informative. Describe what was possible during each period rather than only writing that the medicine was good or bad.

The specialist may change timing or formulation, or add a medicine with a different mechanism. Dopamine agonists, MAO-B inhibitors, and COMT inhibitors have different benefits and risks. Adding treatment does not necessarily mean the disease has reached a final stage. NICE recommends specialist input when motor fluctuations or dyskinesia develop and cautions against abrupt withdrawal or unsupervised medication holidays. A hospital admission or an episode of poor swallowing also needs a medication plan, because an ordinary ward timetable may not match the person's usual needs. NICE management recommendations

Rehabilitation should practice the activities that are difficult

Medication can help movement while leaving problems with turning, getting out of bed, crossing a doorway, or managing a second task while walking. Physical therapy assesses gait, balance, strength, and fitness and can select suitable exercises and cueing strategies. Intensity needs to reflect falls, cardiovascular limitations, cognition, and the ability to follow instructions. An online exercise program is not a universal prescription, particularly for someone who freezes, becomes faint on standing, or has recently fallen. American Physical Therapy Association guideline

Occupational therapy considers how tasks are completed in the actual environment: clothing, bathroom arrangements, handwriting, cooking, and other routines. An aid is useful if the person can use it reliably, not simply because it looks sophisticated. For a period of rehabilitation in China, request a home program with clear assistance needs and limits. A task mastered in an uncluttered treatment room may be harder in a narrow home bathroom or on stairs. Planning for that environment gives the training a better chance of remaining useful after discharge. Occupational therapy practice guideline

Include sleep, mood, communication, and swallowing

The burden of Parkinson's is not confined to the limbs. Constipation, sleep disturbance, anxiety, depression, dizziness on standing, cognitive change, or hallucinations may become more disruptive than tremor. List the most troublesome recent problems before the appointment rather than waiting for each to be raised by the clinician. A sudden change in attention or new hallucinations can also be related to medication, infection, or another acute illness, so it should not automatically be accepted as inevitable progression.

A softer voice, coughing during meals, unusually long mealtimes, or weight loss warrants assessment of communication and swallowing. Repeatedly telling someone to speak up or changing all food to a chosen consistency without advice may miss the actual problem. The recommendations should connect communication practice, meal positioning, nutrition, and medication administration. If neurology, rehabilitation, and caregiving instructions conflict, ask the teams to resolve them before returning home; the patient should not have to decide which professional instruction to ignore.

Discuss deep brain stimulation when the symptom pattern fits

Deep brain stimulation, or DBS, delivers electrical stimulation to selected brain targets. Specialist evaluation may be useful for some people whose medicines still help but whose fluctuations or dyskinesia remain troublesome, and for selected difficult-to-control tremor. Evaluation examines medication response, cognition, mental health, surgical risk, and the ability to attend programming appointments. DBS does not reliably correct every gait, balance, speech, or cognitive problem, and a successful procedure does not guarantee that medicines can be stopped.

Technology is changing. In February 2025, the FDA approved an optional adaptive-stimulation feature for a specified system with defined clinical conditions. Adaptive programming should not be interpreted as a device independently solving all symptoms. The US approval record also does not establish that the same function is available at a particular hospital in China. Ask about the proposed product's local registration, programming support, charging or replacement requirements, and who will manage problems after the patient returns home. FDA adaptive DBS approval record

Separate a promising treatment from a practical treatment pathway

Continuous drug delivery can be considered in selected people with substantial motor fluctuations. The US-approved subcutaneous foscarbidopa–foslevodopa product, for example, has a dedicated delivery system and administration requirements. It is not a pump that patients should configure by converting their oral tablets themselves. The receiving service must be able to assess, initiate, and troubleshoot treatment, and the person needs a realistic route to supplies and continuing support at home. A foreign product label establishes neither Chinese availability nor an individual appointment for treatment. FDA infusion-product prescribing information

Reports about slowing Parkinson's also need careful reading. The PADOVA study of prasinezumab, reported in 2026, did not meet its primary endpoint; exploratory findings support further investigation rather than an established disease-slowing claim. Japan granted conditional, time-limited approval to the AMCHEPRY cell product in March 2026 for motor symptoms inadequately responding to existing medication. That specific decision does not validate every intervention sold as a stem-cell injection and does not demonstrate that the product is authorized or supplied in China. Patients can follow new evidence while continuing treatments that help current function. PADOVA primary report, Japan AMED approval information

Define what a visit to China is intended to accomplish

Possible purposes include confirming the diagnosis, adjusting a complicated medication schedule, assessing troublesome nonmotor symptoms, arranging rehabilitation, or determining whether a procedure is suitable. Send a medication list, previous benefit and side effects, falls history, and original imaging so the hospital can choose the appropriate appointment. A clear clinical diagnosis does not necessarily require every available test. China's 2026 integrated PET/MRI guideline addresses selected questions and diagnostic uncertainty; it should not be turned into a compulsory imaging package for all patients. Chinese integrated PET/MRI guideline

For budgeting, ask separately about consultation and tests, observation during drug adjustment, rehabilitation, and any proposed procedure or programming. The quotation should identify amounts in renminbi, the time covered, and exclusions. When the treatment direction remains uncertain, a single total for the entire disease course cannot be made reliable by presenting it confidently. Before departure, obtain the exact continuing regimen, what to monitor, and responsibility for follow-up. Those using an implanted device or infusion system need confirmation of support in their home country. These arrangements help a consultation in China become a sustainable improvement in care rather than an isolated intervention.

Sources checked: September 9, 2026. This article provides general patient education. Individual treatment requires assessment by the receiving clinical team.